This inventor holds 1 USPTO granted patent. Top assignee: Rmf Dictagene S.a.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Innovations in Immunology by Ying Men
Introduction
Ying Men is an accomplished inventor based in Lausanne, Switzerland. He has made significant contributions to the field of immunology, particularly through his innovative processes that enhance immunological responses. His work is pivotal in developing new methods for immunization against various diseases.
Latest Patents
Ying Men holds a patent for an "Immunological response potentiation process." This process involves synthetic or genetically engineered antigens that typically exhibit low immunogenicity. The innovative approach embeds these antigens into biodegradable microparticles, which are then dispersed in a biodegradable medium. When administered parenterally, these antigen-loaded microparticles elicit a stronger antibody and T-lymphocyte response compared to traditional aqueous antigen solutions. The immunological potentiation achieved is comparable to that of Incomplete Freund's adjuvant compositions. The microparticles are crafted from biodegradable biopolymers such as polyester, polyanhydride, and polyorthoester, allowing for tailored immunological responses.
Career Highlights
Ying Men is associated with Rmf Dictagene S.A., where he continues to advance his research and development efforts. His innovative work has the potential to significantly impact the field of immunization, providing new avenues for combating diseases caused by viruses, bacteria, protozoa, or tumor cells.
Collaborations
Ying Men collaborates with notable colleagues, including Bruno Gander and Giampietro Corradin. Their combined expertise enhances the research and development efforts at Rmf Dictagene S.A.
Conclusion
Ying Men is a prominent figure in the field of immunology, with a focus on enhancing immunological responses through innovative processes. His contributions are vital for the future of immunization strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile